| 06.06.2017 | Miracor Announces Positive Interim Clinical Data with Novel PiCSO® Impulse System for AMI Patients | Press release |
| 24.05.2017 | Kalina Scott appointed new CFO of Polyphor | Press release |
| 19.05.2017 | Polyphor announces successful end of phase II meeting with FDA for Murepavadin in nosocomial pneumonia | Press release |
| 18.05.2017 | VAXIMM Announces Data from Ph I Trial in Glioblastoma with Oral T-cell Immunotherapy VXM01 to be Presented at ASCO 2017 Annual Meeting | Press release |
| 11.05.2017 | BioMedPartners, with Its BioMedInvest III Fund, Invests in EUR 15 Million Series A Round of Cardiovascular Start-Up Cardior Pharmaceuticals | Press release |
| 09.05.2017 | Humedics Announces Appointment of Karsten Damgaard-Iversen as CEO | Press release |
| 09.05.2017 | BC Platforms Closes USD 10 million Series B Financing to accelerate knowledge platform development | Press release |
| 09.05.2017 | Vaximm Announces Collaboration with Merck KGaA and Pfizer | Press release |
| 02.05.2017 | BioMedInvest sells its stake of idiag AG to a private investor | Press release |
| 19.04.2017 | Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech | Press release |
| 12.04.2017 | Polyphor Announces Closing of CHF 40 Million Private Financing Round | Press release |
| 30.03.2017 | Symetis SA and Boston Scientific Reach USD 435 Million Purchase Agreement | Press release |
| 06.03.2017 | Debra Baker Appointed New CMDO of Polyphor | Press release |
| 06.03.2017 | Dr. Igor Matushansky Appointed Global Head, Research and Development of Hookipa Biotech | Press release |
| 16.02.2017 | BioMedPartners Raise CHF 75 Million in First Closing of Their New Healthcare Venture Fund | Press release |
| 14.02.2017 | Swiss Medtech Symetis Broadens Presence in Structural Heart with Acquisition of U.S. Mitral Valve Device Company Middle Peak Medical | Press release |
| 08.02.2017 | Anergis completes Patient Recruitment in Large-Scale ATIBAR Trial with Ultra-Fast Allergy Immunotherapy AllerT | Press release |
| 24.01.2017 | Anergis SA appoints Dr. Klaus Schollmeier as new Chairman of the Board of Directors | Press release |
| 22.12.2016 | Genticel and Genkyotex Announce Intention to Enter into Strategic Combination | Press release |
| 25.10.2016 | Miracor receives additional funding in Series-C closing to expand clinical and commercial activities with the PICSO® Impulse System | Press release |
| 18.10.2016 | Giacomo di Nepi Appointed New CEO of Polyphor | Press release |
| 20.09.2016 |
Spineart secured a EUR 30 million investment from Gimv |
Press release |
| 13.09.2016 | Inotrem successfully completes its first Ph I clinical trial with MOTREMTM | Press release |
| 01.09.2016 | VAXIMM appoints Dr. Matthias Schroff as Chief Executive Officer | Press release |
| 12.07.2016 | Cell Medica acquires Delenex Therapeutics | Link |
| 11.07.2016 | Ian Crosbie joins Sequana Medical AG as Chief Financial Officer | Press release |
| 01.07.2016 | Former Bayer and Pharmacia Senior Executive Rolf. A. Classon joins the Sequana Medical AG Board as Chairman | Press release |
| 16.06.2016 | Jörn Aldag appointed CEO of Hookipa Biotech | Press release |
| 27.05.2016 | Aleva Neurotherapeutics raises USD 18 million in Series C Financing Round | Press release |
| 25.05.2016 | BioMedPartners strengthens management team | Press release |
| 18.05.2016 | Vaximm ernennt den Pharmaindustrie-Veteran Dr. Jarl Ulf Jungnelius zum Chief Medical Officer | Press release |
| 18.05.2016 | Vaximm appoints Pharmaceutical Industry Veteran Dr. Jarl Ulf Jungnelius as Chief Medical Officer | Press release |
| 10.05.2016 | Occlutech GmbH receives 2016 European Minimally - Invasive Structural Heart Devices Product Line Strategy Leadership Award from Frost & Sullivan | News release |
| 04.04.2016 | Anergis SA closes CHF 5 million Financing Round Extension | Press release |
| 23.03.2016 | Polyphor announces $3 million Award from Cystic Fibrosis Foundation Therapeutics | Press release |
| 02.03.2016 | BC Platforms and Microsoft to Provide expanded Genomic Data Management Solutions in the Cloud | Link |
| 01.02.2016 | Aleva Neurotherapeutics and Greatbatch, Inc. Collaborate on Next-Generation Device for Deep Brain Stimulation (DBS) | Press release |
| 11.11.2015 | Genkyotex's GKT137831 Granted Orphan Drug Designation in the US and EU | Press release |
| 10.11.2015 | Curetis IPO priced at EUR 10.00 per share; raises EUR 40 million | Press release |
| 28.10.2015 | ImevaX strengthens executive management team and supervisory board with key appointments | Press release |
| 22.10.2015 | Ayoxxa is Member of the International EYE-RISK Consortium | Press release |
| 10.09.2015 | Aleva awarded grant from the Michael J. Fox foundation | Press release |
| 28.08.2015 | Aleva appoints Dr. Philippe Dro to its Board of Directors | Press release |
| 09.09.2015 | Genkyotex announces top-line results of Ph II clinical program | Press release |
| 04.03.2015 | Baxter's Bioscience Business acquires biopharmaceutical company SuppreMol GmbH | Press release |
| 02.03.2015 | ImevaX welcomes KfW to investor syndicate in second closing of Series A financing | Press release |
| 08.01.2015 | BioMedInvest AG II leads Series B+ financing round of Miracor Medical Systems GmbH | Press release |
| 07.01.2015 | BioMedInvest AG II co-leads Series D financing round of Genkyotex S.A. | Press release |
| 17.12.2014 | BioMedInvest AG II joins Humedics Series C financing round | Press release |
| 11.12.2014 | Anergis starts Ph II dose ranging trial with Birch Pollen Allergy Vaccine AllerT | Press release |
| 02.12.2014 | Ayoxxa Biosystems extends Series B | Press release |
| 27.11.2014 | EyeSense Attracts Lee’s Pharmaceutical Holdings as Strategic Investor | Press release |
| 28.10.2014 | ImevaX secures EUR 7.5 million in Series A financing to develop highly specific vaccine against Helicobacter pylori infections | Press release |
| 12.09.2014 | Symetis SA receives CE Mark approval for ACURATE neoTM | Press release |
| 28.04.2014 | BioMedInvest AG II co-leads Series C financing of Sequana Medical AG | Press release |
| 13.03.2014 | BioMedInvest AG II joins Inotrem S.A.'s Series A Closing | Press release |
| 13.03.2014 | BioMedInvest AG II portfolio company Activaero acquired by Vectura Group | Press release |
| 05.02.2014 | Anergis SA closes financing round totaling CHF 8 million | Press release |